Molecular genotoxicity profiles of apoptosis-inducing vanadocene complexes

Toxicology and Applied Pharmacology

Volumn 154, Issue 3, 1999, Pages 228-235

  Aubrecht, Jiri ^a   Narla, Rama Krishna ^a   Ghosh, Phalguni ^a   Stanek, Jennifer ^a   Uckun, Fatih M ^a  

^a PARKER HUGHES INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL DNA; CISPLATIN; HEAT SHOCK PROTEIN 70; METAL COMPLEX; METALLOTHIONEIN; PROTEIN C FOS; PROTEIN P53; UNCLASSIFIED DRUG; VANADIUM DERIVATIVE; VANADOCENE COMPLEX;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER CELL DESTRUCTION; CELL STRAIN HEPG2; CONTROLLED STUDY; DNA DAMAGE; DNA RECOMBINATION; DRUG CYTOTOXICITY; GENOTOXICITY; HUMAN; HUMAN CELL; NONHUMAN; PROMOTER REGION;

EID: 0033048549     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1006/taap.1998.8592     Document Type: Article

References (43)

1. Beard S. E., Capaldi S. R., Gee P. Stress responses to DNA damaging agents in the human colon carcinoma cell line, RKO. Mutat. Res. 371:1996;1-13.
2. Brennan R. J., Swoboda B. E., Schiestl R. H. Oxidative mutagens induce intrachromosomal recombination in yeast. Mutat. Res. 308:1994;159-167.
3. Buttitta F., Marchetti A., Gadducci A., Pellegrini S., Morganti M., Carnicelli V., Cosio S., Gagetti O., Genazzani A. R., Bevilacqua G. p53 alterations are predictive of chemoresistance and aggressiveness in ovarian carcinomas: a molecular and immunohistochemical study. Br. J. Cancer. 75:1997;230-235.
4. Carls N., Schiestl R. H. Evaluation of the yeast DEL assay with 10 compounds selected by the International Program on Chemical Safety for the evaluation of short-term tests for carcinogens. Mutat. Res. 320:1994;293-303.
5. Chresta C. M., Arriola E. L., Hickman J. A. Apoptosis and cancer chemotherapy. Behr Inst. Mitt. 1996;232-240.
6. Deschamps J., Meijlink F., Verma I. M. Identification of a transcriptional enhancer element upstream from the proto-oncogene fos. Science. 230:1985;1174-1177.
7. Doyle G., Tobias R. S. Pseudohalides and chelate complexes of bis-(cyclopentadienyl) vanadium (IV). Inorg. Chem. 7:1968.
8. Galli A., Schiestl R. H. On the mechanism of UV and gamma-ray-induced intrachromosomal recombination in yeast cells synchronized in different stages of the cell cycle. Mol. Gen. Genet. 248:1995;301-310.
9. Galli A., Schiestl R. H. Effects of Salmonella assay negative and positive carcinogens on intrachromosomal recombination in G1-arrested yeast cells. Mutat. Res. 370:1996;209-221.
10. 22. FEBS Lett. 322:1993;291-294.
11. Hollander M. C., Alamo I., Jackman J., Wang M. G., McBride O. W., Fornace A. J. Jr. Analysis of the mammalian gadd45 gene and its response to DNA damage. J. Biol. Chem. 268:1993;24385-24393.
12. Hollander M. C., Fornace A. J. Induction of fos RNA by DNA damaging agents. Cancer Res. 49:1989;1687-1692.
13. Kopf-Maier P. Tumor inhibition by titanocene complexes: influence upon two xenografted human lung carcinomas. J. Cancer Res. Clin. Oncol. 113:1987;342-348.
14. Kopf-Maier P. Tumor inhibition by titanocene complexes: influence on xenografted human adenocarcinomas of the gastrointestinal tract. Cancer Chemother. Pharmacol. 23:1989;225-230.
15. Kopf-Maier P. Intracellular localization of titanium within xenografted sensitive human tumors after treatment with the antitumor agent titanocene dichloride. J. Struct. Biol. 105:1990;35-45.
16. Kopf-Maier P., Kopf H. Tumor inhibition by titanocene dichloride: First clues to the mechanism of action. Naturwissenschaften. 67:1980;415-416.
17. Kopf-Maier P., Krahl D. Intracellular distribution of titanium after treatment with the antitumor agent titanocene dichloride: On electron energy loss spectroscopic study. Naturwissenschaften. 68:1981;273-274.
18. Kopf-Maier P., Moormann A., Kopf H. Activity of titanocene dihalides against a human colon carcinoma heterotransplanted to athymic mice. Eur. J. Cancer Clin. Oncol. 21:1985;853-857.
19. Kopf-Maier P., Wagner W., Hesse B., Kopf H. Tumor inhibition by metallocenes: Activity against leukemias and detection of the systemic effect. Eur. J. Cancer. 17:1981;665-669.
20. Kuo L. Y., Kanatzidis M. G., Sabat M., Tipton A. L., Marks T. J. Metallocene antitumor agents. Solution and solid-state molybdenocene coordination chemistry of DNA constituents. J. Am. Chem. Soc. 113:1991;9027-9045.
21. Lowe S. W., Bodis S., McClatchey A., Remington L., Ruley H. E., Fisher D. E., Housman D. E., Jacks T. p53 status and the efficacy of cancer therapy in vivo. Science. 266:1994;807-810.
22. Lowe S. W., Ruley H. E., Jacks T., Housman D. E. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell. 74:1993;957-967.
23. Luethy J. D., Holbrook N. J. The pathway regulating GADD153 induction in response in DNA damage is independent of protein kinase C and thyrosin kinases. Cancer Res. 54S:1994;1902S-1906S.
24. 2. J. Am. Chem. Soc. 112:1990;8949-8952.
25. Moebus V. J., Stein R., Kieback D. G., Runnebaum I. B., Sass G., Kreienberg R. Antitumor activity of new organometallic compounds in human ovarian cancer cell lines and comparison to platin derivatives. Anticancer Res. 17:1997;815-821.
26. Mosser D. D., Theodorakis N. G., Morimoto R. I. Coordinate changes in heat shock element-binding activity and HSP70 gene transcription rates in human cells. Mol. Cell. Biol. 8:1988;4736-4744.
27. Mueller H., Eppenberger U. The dual role of mutant p53 protein in chemosensitivity of human cancers. Anticancer Res. 16:1996;3845-3848.
28. 22. J. Med. Chem. 37:1994;1936-1941.
29. Murthy M. S., Rao L. N., Kuo L. Y., Toney J. H., Merks T. J. Antitumor and toxicologic properties of oreganometallic anticancer agent vanadocene dichloride. Inorg. Chim. Acta. 152:1988;117-124.
30. Nelsen B., Hellman L., Sen R. The NF-kappa B-binding site mediates phorbol ester-inducible transcription in nonlymphoid cells. Mol. Cell. Biol. 8:1988;3526-3531.
31. O'Dwyer P. J., Johnson S. W., Hamilton T. C. Cisplatin and its analogues. Cancer, Principles and Practice of Oncology. 1997;Lippincott and Raven, New York. p. 418-432.
32. Richards R. I., Heguy A., Karin M. Structural and functional analysis of the human metallothionein-IA gene: Differential induction by metal ions and glucocorticoids. Cell. 37:1984;263-272.
33. Rushmore T. H., Morton M. R., Pickett C. B. The antioxidant responsive element. Activation by oxidative stress and identification of the DNA consensus sequence required for functional activity. J. Biol. Chem. 266:1991;11632-11639.
34. Schiestl R. H. Nonmutagenic carcinogens induce intrachromosomal recombination in yeast. Nature. 337:1989;285-288.
35. Schiestl R. H., Gietz R. D., Mehta R. D., Hastings P. J. Carcinogens induce intrachromosomal recombination in yeast. Carcinogenesis. 10:1989;1445-1455.
36. Stein B., Rahmsdorf H. J., Steffen A., Liftin M., Herrlich P. UV-induced DNA damage is an intermediate step in UV-induced expression of human immunodeficiency virus type 1, collagenase, c-fos and metahothioine. Mol. Cell. Biol. 9:1989;5169-5181.
37. Todd M. D., Lee M. J., Williams J. L., Nalezny J. M., Gee P., Benjamin M. B., Farr S. B. The CAT-Tox (L) assay: a sensitive and specific measure of stress-induced transcription in transformed human liver cells. Fundam. Appl. Toxicol. 28:1995;118-128.
38. Toney J. H., Brock C. P., Marks T. J. Aqueous coordination chemistry of vanadocene dichloride, with nucleotides and phosphoesters. Mechanistic implication for a new class of antitumor agents. J. Am. Chem. Soc. 108:1986;7263-7274.
39. Vincent R., Goegan P., Johnson G., Brook J. R., Kumarathasan P., Bouthillier L., Burnett R. T. Regulation of promoter-CAT stress genes in HepG2 cells by suspensions of particles from ambient air. Fundam. Appl. Toxicol. 39:1997;18-32.
40. Waddick K. G., Uckun F. M. Innovative treatment programs against cancer. II. NFκB as a molecular target. Biochem. Pharmacol. 57:1999;9-17.
41. Wilkinson G., Birmingham J. M. Bis-cyclopentadienyl compounds of Ti, Zr,V, Nb, and Ta. J. Am. Chem. Soc. 76:1954;4281-4284.
42. Wooden S. K., Li L. J., Navarro D., Qadri I., Pereira L., Lee A. S. Transactivation of the grp78 promoter by malfolded proteins, glycosylation block, and calcium ionophore is mediated through a proximal region containing a CCAAT motif which interacts with CTF/NF-I. Mol. Cell. Biol. 11:1991;5612-5623.
43. Zhan Q., Carrier F., Fornace A. J. Jr. Induction of cellular p53 activity by DNA-damaging agents and growth arrest. Mol. Cell. Biol. 13:1993;4242-4250.